Exane Derivatives’s Health Catalyst HCAT Stock Holding History

Exane Derivatives’s Portfolio HCAT Stock Details HCAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$623	Hold
2022 Q1	$1.12K	Hold
2021 Q4	$1.7K	Sell
2021 Q3	$2.25K	Hold
2021 Q2	$2.51K	Sell
2021 Q1	$4.12K	Buy
2020 Q4	$3.27K	Buy